Retinitis Pigmentosa Market Outlook to Strengthen During the Forecast Period (2026-2036) with Growing Focus on Disease-Modifying Therapies | DelveInsight

Positive

AI Analysis

Summary

DelveInsight publishes a market outlook for retinitis pigmentosa, projecting steady growth through 2036 driven by increased awareness of inherited retinal disorders and advances in disease-modifying therapies and genetic testing.

Importance:2/10

Sentiment:

0.30

retinitis pigmentosainherited retinal disordersdisease-modifying therapiesgenetic testingmarket outlook

Read the original article

Published by PR Newswire Pharma on September 29, 2026 2:31 PM

Read Original